Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-16

Clinical Trial Update: Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating morphine to maximize benefits of exercise training in patients with chronic obstructive pulmonary disease or interstitial l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)

Snippet

Sponsor: Dennis Jensen, Ph.D. | Conditions: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease | Phase 2 | Status: UNKNOWN